» Articles » PMID: 31698797

Variation in Lipid Components from 15 Species of Tropical and Temperate Seaweeds

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2019 Nov 9
PMID 31698797
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The present study describes the variation in lipid components from 15 species of seaweeds belonging to the Chlorophyta, Ochrophyta, and Rhodophyta phyla collected in tropical (Indonesia) and temperate (Japan) areas. Analyses were performed of multiple components, including chlorophylls, carotenoids, and polyunsaturated fatty acids (PUFAs), and alpha tocopherol (α-Toc). Chlorophyll (Chl) and carotenoid contents varied among phyla, but not with the sampling location. Chl a and b were the major chlorophylls in Chlorophyta. Chl a and Chl c were the main chlorophylls in Ochrophyta, while Chl a was the dominant chlorophylls in Rhodophyta. β-Carotene and fucoxanthin were detected as major seaweed carotenoids. The former was present in all species in a variety of ranges, while the latter was mainly found in Ochrophyta and in small quantities in Rhodophyta, but not in Chlorophyta. The total lipids (TL) content and fatty acids composition were strongly affected by sampling location. The TL and PUFAs levels tended to be higher in temperate seaweeds compared with those in tropical seaweeds. The major PUFAs in different phyla, namely, eicosapentaenoic acid (EPA) and stearidonic acid (SDA) in Ochrophyta, α-linolenic acid (ALA) and SDA in Chlorophyta, and EPA in Rhodophyta, accumulated in temperate seaweeds. Chlorophylls, their derivatives, and carotenoids are known to have health benefits, such as antioxidant activities, while PUFAs are known to be essential nutrients that positively influence human nutrition and health. Therefore, seaweed lipids could be used as a source of ingredients with health benefits for functional foods and nutraceuticals.

Citing Articles

Lipidomic Characterization and Antioxidant Activity of Macro- and Microalgae Blend.

Marques F, Lopes D, Conde T, Melo T, Silva J, Abreu M Life (Basel). 2023; 13(1).

PMID: 36676180 PMC: 9865938. DOI: 10.3390/life13010231.


Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review.

Jaworowska A, Murtaza A Int J Environ Res Public Health. 2023; 20(1).

PMID: 36613050 PMC: 9819613. DOI: 10.3390/ijerph20010730.


Marine Compounds for Melanoma Treatment and Prevention.

Montuori E, Capalbo A, Lauritano C Int J Mol Sci. 2022; 23(18).

PMID: 36142196 PMC: 9499452. DOI: 10.3390/ijms231810284.


Assessment of Arabian Gulf Seaweeds from Kuwait as Sources of Nutritionally Important Polyunsaturated Fatty Acids (PUFAs).

Al-Adilah H, Al-Sharrah T, Al-Bader D, Ebel R, Kupper F, Kumari P Foods. 2021; 10(10).

PMID: 34681494 PMC: 8536129. DOI: 10.3390/foods10102442.


Characterization of Bioactive Components in Edible Algae.

Pereira L Mar Drugs. 2020; 18(1).

PMID: 31963775 PMC: 7024186. DOI: 10.3390/md18010065.

References
1.
Kumari P, Bijo A, Mantri V, Reddy C, Jha B . Fatty acid profiling of tropical marine macroalgae: an analysis from chemotaxonomic and nutritional perspectives. Phytochemistry. 2012; 86:44-56. DOI: 10.1016/j.phytochem.2012.10.015. View

2.
MacArtain P, Gill C, Brooks M, Campbell R, Rowland I . Nutritional value of edible seaweeds. Nutr Rev. 2008; 65(12 Pt 1):535-43. DOI: 10.1301/nr.2007.dec.535-543. View

3.
Alves C, Silva J, Pinteus S, Gaspar H, Alpoim M, Botana L . From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds. Front Pharmacol. 2018; 9:777. PMC: 6089330. DOI: 10.3389/fphar.2018.00777. View

4.
Viera I, Perez-Galvez A, Roca M . Bioaccessibility of Marine Carotenoids. Mar Drugs. 2018; 16(10). PMC: 6213429. DOI: 10.3390/md16100397. View

5.
Gomez-Guzman M, Rodriguez-Nogales A, Algieri F, Galvez J . Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders. Mar Drugs. 2018; 16(8). PMC: 6117645. DOI: 10.3390/md16080250. View